Top

Netherlands Heart Journal

Gepubliceerd in:

01-09-2010 | Special article

Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?

A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system

Auteurs: B. E. Claessen, G. W. Stone, P. C. Smits, E. Kedhi, W. J. Kikkert, J. J. Piek, J. P. S. Henriques

Gepubliceerd in: Netherlands Heart Journal | Uitgave 9/2010

Abstract

Treatment options for coronary revascularisation include percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). In the ‘synergy between PCI with TAXUS and cardiac surgery (SYNTAX)’ trial, PCI and CABG using state-of-the-art techniques (using paclitaxel-eluting stents and arterial grafts, respectively) were compared in the treatment of complex coronary artery disease. In Syntax, PCI was inferior to CABG at one year, entirely due to an increased repeat intervention rate. We hypothesised that the use of a superior drug-eluting stent system could reduce the need for repeat intervention. (Neth Heart J 2010;18:451-3.)

vorige artikel ‘Ins’ and ‘outs’ of triple therapy

volgende artikel Dilemma in the cardiac catheter laboratory

Schatz RA, Palmaz JC, Tio FO, Garcia F, Garcia O, Reuter SR. Balloon-expandable intracoronary stents in the adult dog. Circulation. 1987;76:450-7.

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-72.

Ruygrok PN, Desaga M, Van Den Branden F, Rasmussen K, Suryapranata H, Dorange C, et al. One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study. EuroIntervention. 2007;3:315-20.

Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA. 2008;299:1903-13.

Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet. 2010;375:201-9.

Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med. 2010;362:1663-74.

Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51.

Titel: Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?
A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system
Auteurs: B. E. Claessen
G. W. Stone
P. C. Smits
E. Kedhi
W. J. Kikkert
J. J. Piek
J. P. S. Henriques
Publicatiedatum: 01-09-2010
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 9/2010
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/BF03091813

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 9/2010

Early versus late ST-segment resolution and clinical outcomes after percutaneous coronary intervention for acute myocardial infarction

Endovascular stenting for aortic (re)coarctation in adults

Thrombus aspiration in a series of patients with stable or unstable angina pectoris and lesion-site thrombus formation

Percutaneous mitral valve repair using the edge-to-edge technique in a high-risk population

Patients with coronary stenosis and a fractional flow reserve of ≥0.75 measured in daily practice at the VU University Medical Center

Dilemma in the cardiac catheter laboratory